

















by defects in one of severalsteroidogenicenzymesinvolvedin the synthesisof oS ~
cortisol from cholesterol in the adrenal glands. More than90% of cases are E: I
causedby21-hydroxylasedeficiency,andtheseverityof the resultingclinical O C\i
symptoms varies according to the levei of 21-hydroxylase activity. ~
21-Hydroxylase deficiency is usually caused by mutations in the CYP21A2 g
gene, which is located on the RCCX module, a chromosomal region highly 'I-
prone to genetic recombination events that can result in a wide variety of (d
complex rearrangements, such as gene duplications, gross deletions and .U)
geneconversionsof variableextensions.Moleculargenotypingof CYP21A2.S!
and the RCCX module has proved useful for a more accurate diagnosis of the e-
disease, and prenatal diagnosis. This article summarises the clinical 8-
featuresof 21-hydroxylasedeficiency,explainscurrentunderstandingof the ~
disease at the molecularlevei,and highlightsrecentdevelopments,particularly::
in diagnosis. ~
(I)
with changes in the levels of sex steroid -C
honnones, which interfere with primary and
secondarysexualdevelopmentfromfetalto adult eu
life. Cortisol synthesisis positivelyreguIatedby 16
adrenocorticotropic honnone (ACTH) produced ~
by theanterior pituitary, which in turn is controlled E:




Congenitaladrenalhyperplasia(CAH) is a group
of autosomal recessive disorders of adrenal
steroidogenesischaracterisedby a completeor
partial deficiencyof one of the adrena!enzymes
necessary for the synthesis of cortisol from
cholesterol.The resultingdecreasein cortisolor in
cortisoland aldosteroneproductionis associated
Congenitaladrenalhyperplasia:
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synthesisedby the zona glomerulosaof the-
adrenal cortex, regulatesthe excretionof ~ ~
electrolytes in the kidney and maintains U m
intravascular volume and blood pressure: it ~ ~
enhances the reabsorption of sodium, O ><
accompaniedby waterand chlorideretention,E O









secretedby the hypothalamus.Low levels of
cortisol synthesislead to an overproductionof
ACTH; this continuouslystimulatesthe adrenal
gland (in order to producemorecortisol),giving
risetohyperplasiaof theadrenaltissue(Refs1,2).
The threemain categoriesof steroidhonnones
(mineralocorticoids,glucocorticoidsand adrenal
androgens) are synthesised in the adrenal
cortex from cholesterol. The enzymes (and
correspondinggenes)necessaryfor thesuccessive
stepsof steroidhonnonebiosynthesisaredepicted
in Figure 1. The differentclinical phenotypesof
CAH are best understoodby a comprehensive
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promote the normal differentiation of female ~""C
externalgenitalia(Ref.5). -
Dehydroepiandrosteronea dandrostenedione~ m
aretheadrenalandrogensproducedmainlyby gmthe adrenal zona reticularis. In normal - -
physiologicalconditions,thesetwo sex steroids O ~
(whichareweakandrogens)haveno significantE O
functionin primary sexualdifferentiationduring Q) ~
early male and female fetal life. However, J: ~
duringthisperiodof life,someof theenzymatic+-' J:
defects that impair cortisol biosynthesis s::: I
lead to accumulationof sexhormoneprecursors, O C\iwhich are convertedto high doses of UJ
dehydroepiandrosteroneand androstenedione:J
and subsequentlymetabolisedto testosterone(J
and dihydrotestosterone,mainly in peripheralO
tissues.Thesetwo morepotentandrogensinduce ~
virilisation of the externalgenitaliain females, eu






















mainly by potassiumlevels and by the renin-
angiotensin system. The renin hormone -
produced by the kidney in response to
hypotension, lowered intravascularvolume, or
hyperkalaemia - c1eaves angiotensinogen
(produced by the liver) to angiotensinI. This
peptide, under the action of angiotensin-
converting enzyme (mainly present in the
pulmonary endothelium), is converted to
angiotensin 11.Angiotensin 11 stimulates the
zona glomerolosato increasethebiosynthesisof
aldosterone(Ref.4).
Cortisol, the principal glucocorticoid, is
produced by the adrenal zona fasciculata.
Cortisolhasmultipleand importantfunctionsin
most of the metabolicpathways:it plays a key
role in blood sugar maintenance,promoting
gluconeogenesisduring periods of physical or
psychological stress, regulatesblood pressure
and homeostasis,and supports cardiovascular
and immunologicalfunctions.In addition,it was
recently demonstratedfor the first time that







enzymearegivenin italics(CYPgenesymbolsshowthatthecorrespondingenzymeis a memberof the
cytochromeP450superfamily).The steroidogenicacuteregulatoryprotein(STAR)promotescholesterol
transporttotheinnermitochondrialmembrane(notshown)(Ref.140).Thefirststepofsteroidogenesisisthe
conversionof cholesterolto pregnenolone;this requiresthree reactions(20a-hydroxylation,22-




steps that culminatein aldosteronebiosynthesisare performedby a singleenzyme- aldosteronesynthase
(encodedbyCYP1182 gene)- whichhasthreeenzymaticactivities:11f3-hydroxylationofdeoxycorticosterone,
18-hydroxylationand 18-oxidationof corticosterone.(b) Glucocorticoidsynthesis.To producethe
glucocorticoidcortisol(inthezonafasciculata),theCYP17A1-encodedenzymecatalysesthebioconversion
of pregnenolone to 17-hydroxypregnenolone.3f3-hydroxysteroiddehydrogenase uses
17-hydroxypregnenoloneas a substrate,convertingit to 17-hydroxyprogesterone,whichis aiso produced
by the 17a-hydroxylationof progesterone.21-hydroxylasemediates the bioconversionof
17-hydroxyprogesteroneto 11-deoxycortisol,which is convertedinto cortisol by the action of
11f3-hydroxylase.(c)Sexsteroidhormonesynthesis.Theproductionofadrenalandrogensresultsfromthe
conversionof 17-hydroxypregnenoloneto dehydroepiandrosteronebytheCYP17A1 enzymeas a resultof
its 17,20-lyaseactivity,and dehydroepiandrosteroneis subsequentlyconvertedby 3f3-hydroxysteroid
dehydrogenaseto androstenedione.The latter is also convertedby the CYP17A1 enzymefrom
17-hydroxyprogesterone(Ref.7).Thereareseveralisozymeswith 17f3-hydroxysteroiddehydrogenase
activity.Whiletype5isozymeHSD1785(encodedbyAKR1C3)convertsandrostenedioneintotestosterone
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Cholesterol side chain cleavage
(flrst and rate-limiting step of
steroidogenesis) Is blocked:









hypovolaemia, failure to thrive,
vomiting, hypoglycaemia,
lethargy. 46,XX: spontaneous
puberty mayoccur, with menstrual
cycles often anovulatory. 46,XY:
phenotypically female; neverenter
puberty. Individuais with mild
CLAH and normal male genitalia
have been described
Usually incompatible wíth term
gestatlons because of low levels
of progesterone productlon by
placenta; adrenal insufficiency;
rare cases with clinical

















































CAH cases in 82,83,







































































































































hypertension. 46,XY: bom with
ambiguous genitalia or complete
female phenotype; hypertension.










Hypertension with or without
hypokalaemia; rapid somatic
growth; bone age acceleration;
short adult stature. 46,XY: early
puberty; spermatogenesis may be
impaired. 46,XX: bom with




Mild form: androgen excess signs
in female children; hirsutism and









































































































Impaired electron transfer from
NADPH to steroidogenic type 11
P450 enzymes
(CYP17A1, CYP21A2 and
CYP19A1), leading to partial








biosynthesis of cortisol and, in
most severe cases, aldosterone;
accumulation of progesterone and
17-hydroxyprogesterone;
increased secretion of adrenal
androgens
Majorclínicalfeatures







syndrome (ABS). Patients without
ABS and with ambiguous genitalia
or disordered steroidogenesis
have also been described. 46,XY:
undermasculinisation at birth and
defective pubertal development.
46,XX: variable virilisation of





feeding, vomiting, failure to thrive.
46,XX: bom with variable degrees
of external genitalia virilisation
Slmple virllising form: premature
pubarche, rapid linear growth and
advanced bone age with short
adult stature, Impaired fertility.
46,XY: progressive penile
enlargement, smali testes. 46,XX:





puberty, accelerated growth, short















t ACTH or normal
t CortisolalterACTH stlmulation
t Oestradiol







































Abbreviations: ACTH, adrenocorticotropic hormone; CAH, congenital adrenal hyperplasia; DHEA, dehydroepiandrosterone; FSH, follicle-stimulating hormone; hCG, human chorionic






















































































causeCAH are defectsin 21-hydroxylase,1113-
hydroxylase,313-hydroxysteroidehydrogenase,
and less frequently 17a.-hydroxylasej17,20-
lyase, cholesterol 20-22-desmolaseand the
transporter protein StAR (steroidogenicacute
regulatoryprotein). In addition, a new form of
CAH was recentlydescribed,characterisedby
deficiencies in both 21-hydroxylaseand 17a.-
hydroxylasej17,20-lyaseactivities as a result
of mutations in the electron donor enzyme
P450 oxidoreductase(POR) (Refs 9, 10). Most
patients with POR deficiency have skeletal
malformations,genital anomaliesin both sexes
and abnormalsteroid profiles (Refs 10, 11,12).
The clinical and molecular featuresof alI these
enzymatic defects are summarised in Table 1.
For deficiency in 21-hydroxylase, the main
subjectof this paper,a more detailedreview is
presentedin thenextsections.
48
Clinical features of 21-hydroxylase
deficiency
21-hydroxylasedeficiency(21-0HD) is themost
commoncauseof CAH, accountingfor 90-95%
of alI cases. Patients with 21-OHD have a
deficiency in cortisol biosynthesis, which in
most of theseverecasesis also accompaniedby
aldosteronedeficiency.The decreasedadrenal
secretion of cortisol gives rise, because of
the absence of negative feedback to the
hypothalamus and pituitary, to an increased
secretion of CRH and ACTH. The steroid
precursors prior to this enzymatic deficiency
(progesteroneand 17-hydroxyprogesterone)are
accumulatedand shunted through the adrenal
androgen biosyntheticpathway. The increased
secretionof adrenalandrogensfrom the eighth
weekof gestation,and theresultingproductionof
high levels of testosteroneand dihydrotesto-
sterone,particularlyaffectssexualdilierentiation
in females, and causes advanced somatic
development in both sexes during childhood
(Ref.13).Clinically,althoughthereis a continuous
spectrumof phenotypicmanifestationsassociated
with this disease,it has been useful to divide
21-0HD into three forms: salt-wastingclassical
21-0HD, simplevirilising classical21-0HD, and
nonclassical21-OHD.
Classical21-0HD



























patientsusualIy presentbetween the first and
fourth weeks of age with hyponatraemia,
hyperkalaemia,hyperreninaemia,hypovolaemic
shock and hypoglycaemia.Other symptomsare
also common, such as lethargy,poor feeding,
vomiting and failure to thrive. In the female
fetus, androgenexcesscausesvariable degrees
of external genitalia virilisation, and
consequently newborn females have genital
ambiguityor male-resemblingexternalgenitalia
with bilateralcryptorchidism,which may result
in errors of sexassignmentatbirth. In the male
fetus, the testicular androgens normally
produced at high levels induce the normal
masculinisation of the external genitalia, and
the excessof adrenalandrogensusually has no
effect until childhood, although sometimesa
macrogenitossomiaat birth is observed. By Cd
contrast to the situation in affectednewborn .U)
females, where the presence of genital m
ambiguitycontributesto the diagnosisof severe1S.
21-0HD, the normal external genitalia in ~
affected newborn males do not alert CI)
paediatriciansto the diagnosisof a severeform ~
of CAH beforetheonsetof asalt-wastingcrisis..c:
This critical health condition can lead to death-
if appropriatemedical assistanceis not m
available(Refs13,14). c:
Thesimplevirilisingformof 21-0HDoccurs~
in arounda quarterof the casesof classical1J
21-0HD.In thisformofCAH, as21-hydroxylasem
activityis residualbutnotcomplete,and-
becausetheadrenalglandis stimulatedby the .fi
renin-angiotensinsystem,adequatelevelsof .2
aldosteronearestillproduced,allowingnormal CI)
sodium homeostasis.Adrenal glands under tn
continuousstimulationby increasedlevelsof c:
ACTH may synthesiseapproximatelynormal O
levelsof cortisol,althoughcortisolprecursorsO
are still accumulated and consequent1y
directed into the biosynthetic pathway of
adrenocorticalandrogens.As mentionedabove,




fetus, and femalesare consequentlybom with
variabledegreesof externalgenitaliavirilisation,
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Prevalenceof CAH arising from 21-0HD ::s
NeonatalscreeningforclassicalCAH arisingfrom O
21-0HD, established mainly in Caucasian O
populations, found an overall prevalence of ~
approximately1/15000live births,rangingfrom m




1/280 among Yupik Eskimos (Alaska) and 8-
1/2100in the island of La Reunion(Indian ~
Ocean)(Ref.17). "e
The milder, nonclassicalform of 21-OHD is -
muchmorecommon,with a prevalenceof 1/ m
100 in the generalpopulation,althougha c:
higher ethnic-specificincidence is found ~








(sometimesa mild clitoromegalyis observed),
and both males and femalesmay show signs
of androgen excess at any time after
postnatal development. Children may
present with early pubic hair, precocious
puberty, and accelerated growth associated
with advanced bone age. Females may
show one or more of the following
symptoms: hirsutism, temporal baldness,
delayed menarche, polycystic ovaries and
menstrual irregularities. Adult males and
females may have cystic acne, impaired
fertility, and short stature due to premature
epiphyseal fusion. In addition, asymptomatic
patients may be identified and diagnosed
during the familial screening of one affected
individual (Ref.16).
ranging from mild hypertrophy of the clitoris
and partial fusion of the labioscrotalfolds to a
phallic urethra and a complete fusion of the
labioscrotalfolds. It is important to emphasise
that for children with external genitalia
ambiguity or with normal male genitalia
without palpable testes, the possibility of
21-0HD should be considered (among the
different causesof genital ambiguity,21-OHD
is the most frequent). In the 46,XY fetus, the
adrenal excessof androgen precursors has no
effecton the externalgenitaliamasculinisation.
Later in life, untreated children of both
sexes with simple virilising 21-0HD develop
signs of androgen excessthat usually include
prematureappearanceof pubic hair, followed
by development ofaxillary hair, acne, facial
hair, rapid linear growth and advanced bone
age, although, due to premature epiphyseal
fusion, patients usually have a short adult
stature.After childhood, untreatedfemalesdo
not undergonormal pubertyand in most cases
present clitoral enlargement,hirsutism, male-
pattern baldness, cystic ovaries, and
amenorrhoea or irregular menses, and
consequently primary infertility or reduced
fertility. Prepubertal males usually have
progressive penile enlargement, small testes
and later in life invariably show seriously
impaired fertility (Ref.13).
The phenotypic variability in degree of
external genitalia ambiguity in females with
classical 21-0HD might reflect differences in
the efficiency of conversion of the adrenal
androgensinto the two morepotentandrogens,
as well as the androgen receptor gene
expression leveI, the affinity of the androgen
receptor for its ligands (testosterone and
dihydrotestosterone),and the efficiency of
androgen receptor transactivation on target
androgen-regulatedgenes(Ref.15).
fi)
e Hormonal diagnosisof 21-0HD




Instead,diagnosisof 21-0HD is based on
elevatedbaselineand ACTH-stimulatedlevels







Patientswith the salt-wastingform show
the highest 17-hydroxyprogesteronel vels
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Nonclassical21-0HD
The nonclassicalform of 21-0HD is associated
with less severe symptoms of
hyperandrogenisation.This is due to a mild
deficiency of 21-hydroxylase and to slightly
elevated levels of 21-hydroxylase adrenal
steroid precursors. Aldosterone biosynthesis
is not disturbed in patients with nonclassical
21-0HD. The clinical manifestationsof mild
androgen excess are variable. Females are





of >20000ngj dI, while patients with the
simple virilising form usually have
17-hydroxyprogesterone concentrations of
10000-20000ngjdl (Ref. 13); however, some
patientswith these two clínical forms present
17-hydroxyprogesteronelevels that overlap,
and a cut-off cannot be established. The
nonclassical 21-0HD patients have lower
17-hydroxyprogesterone after ACTH
stimulation (1000-10000ngj dl). Basal serum
17-hydroxyprogesteronelevels in most of the
latter patients are not distinguishable from
heterozygotesfor classical or nonclassical 21-
OHD. The large data obtained from neonatal
screening of CAH demonstratedthat preterm
and stressed newboms have higher
17-hydroxyprogesteronelevels in serum than
babies bom at term, generatingfalse-positive
results. In order to avoid these false-positive
results, cut-off values were establishedbased
on gestationalage (in Japan and Europe) or on
birth weight (in the USA). The neonatal
screening is also not efficient in the
identification of newboms with the
nonclassicalform of the disease.It is important
to recognise that other steroidogenic
deficiencies,such as 1113-hydroxylasedeficiency
and 313-hydroxysteroid dehydrogenase
deficiencytype 2, may be misdiagnosedas 21-
OHD. In thesecases,it is importantto perform
a completeadrenocorticalhormoneprofile and
evaluate ratios of precursors versus products
afterACTH stimulation(Refs13,19).
8
Molecular features of 21-0HD
The CYP21A2 locus
Human adrenal 21-hydroxylaseis encodedby
the CYP21A2 gene, also previously called
CYP21 and CYP21B, which is located on
6p21.3within class m HLA, ~30 kb from a
pseudogene(CYP21A1P;known also asCYP21P
and CYP21A). Thesetwo genesshareabout98%
homology in their ten exonsand about 96%in
the introns, but CYP21A1P is inactivebecause
of the presenceof severaldeleteriousmutations
(Refs21,22).The geneand the pseudogeneare
included in what is called the RCCX region
(Fig. 2), which, in the most common alleles,
has a bimodular form (RCCX-RCCX),
composedof two setsof four genesarrangedin
tandem: RP1-C4A-CYP21A1P-TNXA-RP2-- - - - -
Ç4B-ÇYP21A2-TNKB (Ref. 23). The C4A and
C4B genes code for the fourth componentof
't->..
serumcomplement,RPl encodesa putativeO (.)
nuclearproteinsimilar to DNA helicase,"~s::
andRP2 is a truncated,nonfunctionalcopyof 0 "~
RPl. TNXB encodesa putative extracellularm"2
matrix protein (tenascinX) and overlaps.c 10
the CYP21A2geneon the oppositeDNA '- "C
strand.Likewise,TNXA is a truncatedcopyof S
TNXB and overlaps CYP21Alp, also on the :J ~





In October2006,the Human GeneMutation ~
Database (http://www.hgmd.cf.ac.uk/ac/index. s:: I
php) had a total of 103 entries for CYP21A2 O ,...
mutations:87pointmutationsorsmalldeletions0 C\I
or insertions,sevensplicingmutations,and :J
nine gross deletions,duplicationsor gene (.)
conversions. O
As a resultof its structureof repeatedgenes~
arrangedin tandem,the RCCX region is prone m
to a high frequencyof recombinationevents,"U)
which can lead to (1) unequal crossing-overs m
during meiosis, resulting in a wide variety of 1S.
arrangementsdependingon the breakpoints,'-
such as gene duplications and gross gene (1)
deletions encompassingthe C4 and CYP21A2 C.
genes(Refs25,26),or to (2)largeor shortgene~
conversionsin whichtheCYP21A1Pmutations,-
which drasticallyimpair its transcriptionand m
preventthe productionof a functionalenzyme, s::
are transferred to CYP21A2 (Fig. 3). Gross ~
deletionsencompassingvariableportions of "C
C4A,CYP21Alp,TNXA,RP2,C4B,CYP21A2and m
TNXB produce different types of chimaerasin -
the RCCX modules.The resultingallelesmay .fi
havedifferentextentsoftheCYP21A1Psequence"2
in the 5' portionof the 21-hydroxylasegene (1)
attachedto the 3' portion of CYP21A2 C)
(CYP21A1P-CYP21A2chimaeras),or a 5' s::
portionof the TNXA geneattachedto the3' O
portionof TNXB (TNXA-TNXB chimaeras)O
(Ref.27).In bothcases,theresultingalleledoes
not have a functionalCYP21A2 gene. The
CYP21A1P-CYP21A2chimaerasdo not leadto
theproductionof active21-hydroxylasenotonly
becauseof the deleteriousmutationsof the
CYP21A1Pin the5'portion,butalsobecausethe
promotersequenceof thepseudogenehasonly
20% of the transcriptionalactivity of the
CYP21A2promoter(Ref.28).TheTNXA-TNXB
9
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exons have also been reported - namely O
geneconversionsfram exon 1 to 7, fram exon 1 O
to 3, from exon 3 to 7, fram exon 3 to 8, fram
exon 4 to 7, and fram exon 5 to 8 (Refs 29,
33,34,35).
Apart fram gene deletions and large gene
conversions,thereare eight mutationsreported
with a higher frequency in the CYP21A2
gene(Fig.4): g.89C> T (p.P30L),g.655AjC > G
(12 splicing), g.707_714deIGAGACTAC
(p.GllO_Y112delfs), g.999T>A (p.I172N),
ExpertReviewsin MolecularMedicine2007 Publishedby CambridgeUniversityPress
Figure2. The localisationandstructureof the RCCX region.RP1, C4A, C4B, CYP21A2 and TNXB are
functionalgenes;CYP21A1p, TNXA andRP2 are nonfunctionalpseudogenes.TNXA andTNXB areencoded
on the opposite DNAstrand.The sizes (bp)of the CYP21A2 exons (blueboxes)are indicatedabovethem;
the sizes of the intronsare indicatedbetweenthe exons;the numberingof the exons is indicatedbeneath
the boxes. The black solid line representsthe untranslatedregionof the gene and the slashes indicatethe
gene or DNA sequence is longer than shown. Abbreviations:C2, complementcomponent 2; C4A and
C4AB, complement component 4A and 4B; CYP21A1p, cytochrome P450, family 21, subfamily A,
polypeptide 1 pseudogene; CYP21A2, cytochrome P450, family 21, subfamily A, polypeptide2; HLA,
human leukocyteantigen;RO, also known as ROBP (RNA-binding protein);RP1 and RP2, also known as
STK19 andSTK19p, respectively('serinejthreoninekinase19 geneand pseudogene');TNF,tumournecrosis
factor;TNXA, tenascinXA pseudogene;TNXB, tenascinXB. The top halfofthefigure,showingthepositionof
the RCCX regionrelativeto neighbouringgenes on chromosome6, is adaptOOfrom Ref. 7: Donohoue,P.A.,
Parker,K. and Migeon,C.J. (1995)Congenitaladrenalhyperplasia.In The Metabolicand MolecularBases of






30, 31, 32). This may complicatemutation
analysis:oneof theduplicatedcopiesmight
have mutations that are detectedby the
traditionalmethodsbut theotheronemight
be a functional copy, renderingthis allele
perfectly active. Different extentsof gene
conversions comprising several CYP21A2
10
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Differentpossibleformsof theRCCX regionandCYP21A2 gene
ExpertReviewsin MolecularMedicine@2007CambridgeUniversityPress
8
Figure 3. Different possible forms of the RCCX region and CYP21A2 gene. (a)Standardbimodularform
of the RCCX region; (b) trimodularform of the RCCX region,with a duplicationof RP2, C4B, CYP21A2
and TNXB, resultingin a chimaericTNXB- TNXA gene; (c) monomodularform of the RCCX regionarising
from a deletion in the region TNXA-RP2-C4B-CYP21A2- TNXB, resultingin a chimaeric TNXA- TNXB
gene; (d)monomodularform of the RCCX regionarisingfrom a deletionin the regionCYP21A1P-TNXA-
RP2-C4B-CYP21A2, resulting in a chimaericCYP21A1P-CYP21A2 gene; (d1-3) three of the distinct
CYP21A1P-CYP21A2 chimaerasdescribed by Lee (Ref. 27); (e) partialgene conversionof CYP21A2 to
CYP21A1P; (f)completeCYP21A2 geneconversionto CYP21A1P and partialconversionof TNXB to TNXA.
Abbreviations:see Figure2 legend.
g.1683G>T (p.v281L),g.1994C>T (p.Q318X),
g.2108C>T (p.R356W) and g.2578C>T
(p.P453S)(Ref.13).Exceptfor thelastone,all
the other seven mutationsare presentin
CYP21AIP and are presumedto have been
transferred to CYP21A2 by short gene




eventsjust like the othermostfrequentpoint
mutations(Ref.36).Threeof thesemutations
are associatedwith the nonclassicalform of
21-0HD, one is typicallyrelatedto simple
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diagnosis of 21-hydroxylaseby detection of .fi
mutations in the CYP21A2 gene is of major .2




of the CYP21A2 gene from the pseudogene,O
sincethelatteris inactiveandhasmostof the
mutationsof interest.Currently,this step is
usually performed by PCR with primers
specificfor CYP21A2,which do not allow the
concomitant amplification of CYP21AIP
(Refs40,41).The productof this first stepis
used as templateDNA for detectionof
mutationsin thesecondstep.Thescreeningof
the most common mutations is regularly
ExpertReviewsin MolecularMedicine2007 PublishedbyCambridgeUniversityPress
Figure4.CommonmutationsintheCYP21A2gene.Theschematicindicatesthelocalisationoftheeightmost
frequent CYP21A2 mutations in most populations,and the correspondingforms of congenital adrenal
hyperplasia(CAH).The changesin aminoacidsequencearegivenbelowtheexons (exceptfor 655AjC > G,
which affects splicing), and enzymatic activity (based on in vitro studies; Ref. 13) resultingfrom each
mutationcomparedwiththe normal21-hydroxylaseactivityis indicatedin parentheses.Figureadapted,with
permissionfrom PerrinWhite (Universityof Texas SouthwestemMedical Center,Dallas,TX, USA) and The
EndocrineSociety,from Ref. 13:White,P.C. and Speiser,P.W.(2000)Congenitaladrenalhyperplasiadue to
21-hydroxylasedeficiency.EndocrRev21(3),245-291(Copyright2000,the EndocrineSociety).
8)
virilising classical21-0HD, and three to salt-
wastingclassica121-OHD.The mutationg.655A/
C> G has been reportedboth in salt-wasting
and in simple virilising cases.This mutation
activates cryptic splicing receptor sequences
causing the incorrectprocessingof almost all
the mRNA. A small amountof normallyspliced
rnRNA can be detected in cell cultures;
therefore,in the absenceof other mutations,




As discussedabove,21-OHD is diagnosed
biochemically by measuring levels of
17-hydroxyprogesteroneaft r stimulationwith
ACTH, but this methoddoesnot differentiate
12
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performed by PCR-based and/or sequencing
techniques. For example, alIele-specific PCR
using pairs of primersspecificfor the detection
of each of the eight most frequent mutations
has been widely used (Ref. 42), but, more
recent1y, multiplex mini-sequencing has
alIowed the concomitant screeningof alI the
frequent mutations by single-base extension
using a specific primer for each mutation and
fluorophore-labelIed ddNTPs, folIowed by
separation of the fragments by capillary
electrophoresisusing an automatedsequencing
apparatus(Refs29,43,44).When the mutations
detectedby thesemethodsdo not explain the
phenotype exhibited by the patient, novel
mutations can be searched for by screening
the CYP21A2 exons by SSCP (single-strand
conformation polymorphism) analysis, by
DHPLC (denaturing high-performance liquid
chromatography) analysis, or by direct
sequencingof the severalexonsand noncoding
regionsof CYP21A2 (Refs45,46,47).
AlI the above-mentioned techniques fail,
however, to detect gross gene deletions and
duplications,as welI as large geneconversions,
which have a significant frequency in most
populations (Ref. 13). These abnormalitiesare
best characterised if family members are
included, and by using laborious Southem-
blotting methodology with the appropriate
probes for CYP21 and for C4 genes.
TraditionalIy, cDNA probes are used, but
Southem blotting using genomic DNA
CYP21A2 probes has also been described
(Ref. 48). The restriction enzymes most
commonly used are TaqI and BglIl, although
different endonucleaseshave been utilised to
characterisecomplex rearrangementsand extra
copies of C4 and CYP21A2 (Refs 48, 49). In
addition, real-timequantitativePCR has been
recent1y used to rapidly detect CYP21A2
deletionsjconversions(Ref. 50). However, this
method is criticalIy dependenton an accurate
DNA quantification and showed some
discrepancieswhen compared with Southem-
blotting results, particularly when
discriminating between two and three gene
copies. Moreover, it does not alIow the
distinction between gene deletions and gene
conversionsor differentcombinationsof alIeles
with distinct abnormalities.A semiquantitative
strategy based on a two-step PCR and TaqI





showed a very good concordancewith O (,)
Southem blotting,but the interpretationof the"~ c:
results might occasionalIybe difficult and UJ "~
misleading, since it relies on visual m (,)
quantification(on agarosegels) of PCR/.c ;;:
digestion products, which are dependent on ~ ~
PCR yields. For a rapid and easierdetectionof Jg
chimaericgenesandCYP21A2deletions,Lee ~ CI)
and co-workers have recent1ydeveloped a ~ ~
simpler method based on extended PCR - -
folIowedby TaqIrestriction(Ref.23);however,O ~
this does not differentiate total gene E O
conversionsfromCYP21A2completedeletions,CI) ~
nor does it detect gene duplications. Thus, ..s:: ~
although these methods are very useful for +' ..s::
diagnostic purposes because they provide a c: I
rapid, easy and economic means of detecting O ,...
deleteriousgeneabnormalitiesresultingfrom UJ C\I
recombinationevents,the results are often ~
ambiguousandin thosecasesSouthem-blotting(,)




or promoter region of the CYP21A2 gene,it is ió
important to evaluate and predict its 'ã.
consequencesfor 21-hydroxylase activity at ~
differentlevels:(1) thenatureof the amino acid CI)
alteration,associatedstructural alterationsand ~
enzymaticor functional consequences;(2)..s::
possible alterationsof the normal splicing sites-
(eliminationor creationof new splicingsites); m
and (3) impairmentof geneexpression.It is of c:
major importanceto performstructuraland ~
functional studies in vitro, for a better\j
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(p.I172N) was more common;in Portugalboth
thesemutations were detectedwith the same
frequency (Ref. 29); and in Tunisia, the most
frequent mutation was g.1994C> T (p.Q318X)
(Ref. 35). Among nonclassical21-0HD alleles,
the most common mutation is usually either
g.1683G>T (p.V281L) or g.89C> T (p.P30L)
(Refs 29, 55, 59, 60, 61). As Kotaska et aI.
(Ref. 55) concluded, the overall frequency of
mutation g.1683G> T (p.v281L) is higher in
South Europe and North Africa, where the
nonclassicalform of the diseasehas a higher
prevalence.However, the highest frequencyof
this mutationis registeredamongtheAshkenazi
Jews (Jews of Eastem Europeanorigin), with a




CYP21A2 mutationscanbe predictedto causea
certain phenotype - salt-wasting, simple
virilising or nonclassical- on the basis of the
reduction of the enzymatic activity they
produce. However, most CAH patients are
actually compound heterozygous for two or
more mutations.Since21-0HD is an autosomal
recessivedisease,the phenotypeof the patient
should reflectthe mutation that is predictedto
causea lesssevereimpairmentof theenzymatic
activity.This approachto predictingphenotype
hasbeenshowntobecorrectin 80%to ~ 100%
of casesfor null mutations and patientswith
salt-wasting 21-0HD, and for the p.V281L
mutation and patients with nonclassical 21-
OHD (Refs 13,29, 62).Slight deviationsto this
correlation occur in the forms of the disease
with intermediateseverityand with mutations
such as p.I172N, g.655AjC > G or p.P30L,
which in vivo may produce variable 21-
hydroxylaseactivity.Sometimesit is difficult to
differentiatebetween the simple virilising and
nonclassical forms in male patients, because
their symptomsof androgenexcessare usually
not detectedatbirth, so theymay be incorrectly
assigned as nonclassical 21-0HD patients.
Otherwise,someof thecausesthatcontributeto
discrepanciesbetween the predicted and the
patient's phenotypemay be the associationof
mutationsof differentseveritiesin the sameor
in distinct alleles, the existenceof mutations
that impair CYP21A2 geneexpression,and the
presenceof alterations in other genes, which
may disturb 21-hydroxylase function or
expert reviewsinmolecularmedicine
'1->..
expression.It has also beenproposedthatsome O (,)
alterations usually considered to be.~ c:
polymorphisms,uchasp.K102Randp.5268T,UJ .~
mighthavea synergisticeffectwhenpresentin m.2
the same allele, resulting in a decreasedJJ 'I-
21-hydroxylaseactivity (Ref. 59). However,ffi -8deviations to the predicted genotype--
phenotypemight alsobe causedby an incorrect ::s ~
genotyping.Studiesbasedonthescreeningof (,) m
knownmutationsfailtodetectnovelmutations,.!! ~
which might also affect significantlythe O ><
enzymaticactivityor expression.Moreover, the E O
occurrenceof alleledrop-out, in which a certain Q) lo.
allele is preferentiallyamplified by PCR, has J: "'C
beenreported(Refs63,64,65).Patientsmight +' ~
then be incorrectlygenotypedas homozygotes c: I




Some of the above-mentionedgenotypingO
limitations can be minimised by the study of ~
the CYP21A2 gene of both parentsof the m
patient, thus confirming if the detected'~1
mutations are in opposite alleles of the ro
proband.Furthermore,this additionalstudy1i
providesdatausefulfor geneticcounsellingof lo.
thepatientand family,as well as for prenatal&.diagnosisin futurepregnancies.
Pregnanciesat risk for a child affectedwith ~
classicalCAH aresubjectedto prenataltherapy-
with dexamethasone,which must begin in the m
early first trimester in order to efficiently c:
prevent female genital ambiguity. However, ~
there is consensusthat glucocorticoid therapy ~
shouldbe used with cautionbecauseof the ro
associatedrisk of potentialadverseeffects-=
both to the mother (such as weight gain, ~
hyperglycaemia,cutaneousstriae, irritability,.2
gastrointestinal intolerance, and increased Q)
blood pressure) and the fetus (congenital :=
malformations,intrauterinegrowth retardation, ~
mood fluctuations and shyness) - although O
none of these risks has been proved to be U
directly associatedwith the treatment,with
some studies reporting the same frequencyof
fetalmalformationsin pregnanciessubjectedto
dexamethasonetreatmentand in the general
population (Refs13,66).It is thereforedesirable
to perform prenatal diagnosis as early as
possible,since only affectedfemaleswill suffer
from genitaliavirilisation. If the fetus is male
or does not carry CYP21A2 mutations in both
14
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alleles, dexamethasone therapy can be
immediately suspended, saving both mother
and fetus from unnecessary glucocorticoid
exposure(Refs13,66).
In pregnanciesat risk for a child affectedwith
classical CAH, noninvasive early fetal sex
determination from maternal plasma is now
possible(Refs67,68,69),althoughconventional
methodologies are still current1y performed.
Cells obtainedby chorionic villus sampling (at
10-12 weeks of gestation)or by amniocentesis
(at 14-16 weeks)can be cultured and used for
sex determination by PCR amplification of
the SRY (sex-determining region of the Y
chromosome;no cell culture required in this
case),fluorescencein situ hybridisation (FISH)
or conventional karyotyping, as well as for
searching for the CYP21A2 mutations
previously identified in the parents. As a
quality-control measure in prenatal diagnosis,
fetalDNA should be retestedusing informative
tandem repeats (VNTRs or STRs) to ensure
lack of maternal contamination, while
simultaneouslyallowing paternityconfirmation.
Preimplantationgeneticdiagnosis (Refs 70, 71)
has alsobeenused for the diagnosisof 21-0HD
(Ref. 65);however,despite the greatadvantage
of the very earlydiagnosis,this methodologyis
current1ycarried out only in specialisedcentres
(Ref.72).
It is advisableto confirmall prenataldiagnoses
soonafterbirthbecauseofthepossibilityoferrors,
includingfalse-negativediagnosis.It is important
to bearin mind thatde novo mutationsoccur in
the CYP21A2 gene with a considerable
frequency of 1-1.5%, which can complicate
molecular prenatal diagnosis of 21-0HD: the
fetusmight have a mutationthatdoesnot exist
in the parents and that might not be screened
on a first approach(Ref.73).
8
Research in progress and outstanding
research questions
Intenseresearchoverthepastthreedecadesin
human molecular biology associatedwith
humanendocrinologyhasproduceda plethora
of discoveriesthatencompasstheidentification
of genescoding for enzymes,transcription
factors,hormonesandreceptors,physiological
functions of endocrine hormones and
receptors,and the characterisationof the
molecular pathology of numerous
endocrinologicaldiseases,includingnearlyall
~~
forms of CAH. In addition, with this - Ü#ft-
knowledge it has been possible to offer.~ ~
prenataldiagnosisand geneticcounsellingto ti) .!
couplesatriskofhavinganaffectedbabywith m.2
themostsevereformsof CAH. However,the JJ \I-
predictionof phenotypebasedon genotypei.. ..s
may fail in somesituations,namely in the ones ~- ....
associatedwith mutationsof intermediate- ~
severity, as occurs with some mutations ~m
identified in the deficienciesdescribed above, ~ ~
especially those associated with variable 2 ><
expressivity. This absence of genotype- t: O
phenotypecorrelationis in part due to the Q) J".,
incompleteunderstandingof geneexpression..c: -g.
regulation,which is dependenton multiple +' J::
transcription factors (some of which are still C !
unidentified) that interact with each other and O "'"';
with regulatorysequences.In addition,there UJ C\I
arealsorareformsof CAH andmanycasesof ::s
hyperandrogenicfemales for whom the (.)
molecular defectis unknown. For theseissues, O
it is expected that in the near future new ::
technologieslike proteomics,tandem mass ~
spectrometry,microchiparraysandultra-rapid.~
DNA genotyping and sequencing will .....
contributeto the identificationof new disease- -:::=
associated genes and new biomarkers. After t:"
elucidating the physiological functions of these (1)
with the use of functional studies and animal P.
models, it is expectedthat the data will help ~
excludethe false-positiveresults frequent1y-
obtainedwith theconventionalimmunoassaysm
used in neonatal screening programmes of t:
CAH, quickly identify the moleculardefectsof e
all the CAH forrns, and contribute to better "t:i
geneticcounsellingand patienttreatrnent. ~
In the future, with the new technologiesof -
genome and proteome analysis, it will be J9
possibleto simultaneouslyevaluatemultiple=s:::
genesor geneproductsdirect1yassociatedwith (1)
CAH and involved in the same or in C)
multiplephysiologicalpathways.Theintegration::
of thesedataobtainedfroma largenumberof a
patients with pharmacogenomicstudies and r'}!
eventuallywith gene therapywill have a great
impact in individual and global health care
(Refs74,75).
At present,there is consideiableexpectation
that genetherapyand autografttransplantation
of genetically modified adrenal cortical stem
cellsor multipotentmesenchymalbonemarrow
cells may achievea definitive cure for patients
with CAH or with other endocrinepathologies
15
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(Ref. 76). Also currently under research are
microRNA molecules that specificalIy regulate
geneexpressionat the post-transcriptionallevel
(Ref. 77): these microRNAs might be applied
in the treatment of hyperandrogenism by
regulating specificalIy the expressionof genes
directly involved in adrenal androgen
biosynthesis,such as CYP17Al.
AlI thesesubjectsarecurrentlyunderintensive
research,so that future expertswill have the
opportunity to comprehensively,efficientlyand
simultaneously integrate the evaluation of
multiple physiological systemsof each patient
and select innovative, individualised, curative
therapeutics.
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Further reading, resources and contacts
~
CYP21A2 allelenomenclature,mutationsand associatedphenotypesare summarisedat:
http:jjwww.cypalleles.kLsejcyp21.htm
The OnlineMendelianInheritancein Man websiteprovidesa registerof humangenes and geneticdisorders:
http://www.ncbLnlm.nih.gov/entrez/query.fcgi?db=OMIM
The CARES foundationwebsite(focusingon CAH) andtheGeneTestswebsite(focusingon geneticscreening)




The Johns HopkinsChildren'sCentersiteabout CAH has usefulinformationaboutthedisease,especiallyfor
patientsand theirfamilies:
http:jjwww.hopkinschildrens.orgjspecialtiesjcategorypagesjcah
The CLAN organisationhelp patientsand familieswith CAH in developingcountriesaccess medication:
http:jjwww.cahclan.org
The HumanGene MutationDatabasecontainsusefuldataabout mutationsin the CYP21A2 gene:
«8
http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CYP21A2
A generaloverviewofthemultipleformsof CAH, genetics,enzymaticdefectsandthehistoryof thisdiseasecan
be found at:
http:jj en.wikipedia.orgjwikijCongenital_adrenaLhyperplasia
Features associated with this article
Figures
Figure1. Principalpathwaysof steroidhormonebíosynthesisfrom cholesterol.
Figure2. The localisationand structureof the RCCX region.
Figure3. Differentpossible forms of the RCCX regionand CYP21A2 gene.
Figure4. Common mutationsin the CYP21A2 gene.
Table
Table 1. Summaryof thevariousenzymaticdefectsthatcause congenitaladrenalhyperplasia.
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